arrow
L

Luca Idolazzi

university of verona
H指数:40
被引数:4,908

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study

意大利临床实践中 ixekizumab 治疗 Psoriatic Arthritis 的两年持续治疗和有效性:ROUTE-IXE 研究结果

2026-11-100
OAAI
Real-world trajectories in psoriatic arthritis under risankizumab therapy

鲁安沙利单抗治疗下银屑病关节炎患者的真实世界轨迹

2026-09-230
PRE
Proton pump inhibitor use and long-term outcomes in systemic sclerosis: a real-life analysis from the EUSTAR database

质子泵抑制剂使用与系统性硬化症长期结局:来自EUSTAR数据库的真实世界分析

2026-09-180
OAAI
Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study

系统性硬化症相关肺动脉高压患者口服抗凝剂的有效性:一项EUSTAR队列研究

2026-09-180
OAAI
Ultrasonographic assessment of the distal interphalangeal joints in psoriatic arthritis and osteoarthritis of the hand: definition and prevalence of elementary lesions to support differential diagnosis

超声评估银屑病关节炎和手部骨关节炎的远端指间关节:支持鉴别诊断的基本病变的定义和患病率

2026-09-070
OA
Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry

系统性硬化症中的癌症:EUSTAR注册研究中的临床关联和预后影响

2026-08-290
OAAI
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR database

系统性硬化症中皮肤钙质沉着症的临床特征及危险因素:来自EUSTAR数据库的见解

2026-04-060
PRE
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis

先期暴露会影响保留吗?一项关于银屑病关节炎中IL-17抑制剂循环治疗的现实世界、多中心评估

2026-03-140
OAAI
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort

系统性硬化症患者中抗-Th/To+患者的临床表型:一项基于欧洲硬皮病试验和研究队列的病例对照研究

2026-03-020
PRE
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR)

作为系统性硬化症预后因素的雷诺现象和首次非雷诺症状的年龄和发病时间: 来自意大利风湿病学会 (SPRING-SIR) 的意大利国家多中心系统性硬化症进展研究注册中心的回顾性分析

2026-02-050
PRE
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry

硬皮病毛细血管镜模式的患病率、分布及其关联:来自意大利SPRING-SIR登记研究的最新见解

2026-01-013
PRE
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry

早期和已确诊系统性硬化症中的胃肠道受累:来自意大利SPRING-SIR国家注册研究的见解

2025-09-010
OAAI
Multimodal ultrasound in the assessment of muscle involvement in systemic sclerosis patients: results from a bicentric study

多模态超声在系统性硬化症患者肌肉受累评估中的应用:一项双中心研究的结果

2025-08-010
OAAI
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology–Rheumatology Clinic: A 24-Week Multicenter Study

贝美克单抗在主要由难治性银屑病关节炎患者组成的联合皮肤科-风湿科门诊中的真实世界有效性:一项24周的多中心研究

2025-07-280
OAAI
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort
2022-03-093
OA